Aclaris Therapeutics Inc (ACRS)
1.175
-0.04
(-3.69%)
USD |
NASDAQ |
May 10, 16:00
1.175
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Total Assets (Quarterly): 197.40M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 197.40M |
| September 30, 2023 | 218.35M |
| June 30, 2023 | 235.65M |
| March 31, 2023 | 229.70M |
| December 31, 2022 | 254.60M |
| September 30, 2022 | 267.63M |
| June 30, 2022 | 277.98M |
| March 31, 2022 | 226.53M |
| December 31, 2021 | 251.21M |
| September 30, 2021 | 263.49M |
| June 30, 2021 | 288.05M |
| March 31, 2021 | 161.40M |
| December 31, 2020 | 70.78M |
| September 30, 2020 | 71.90M |
| June 30, 2020 | 85.00M |
| March 31, 2020 | 96.81M |
| December 31, 2019 | 98.30M |
| September 30, 2019 | 160.42M |
| Date | Value |
|---|---|
| June 30, 2019 | 217.24M |
| March 31, 2019 | 253.18M |
| December 31, 2018 | 275.57M |
| September 30, 2018 | 176.18M |
| June 30, 2018 | 201.82M |
| March 31, 2018 | 220.62M |
| December 31, 2017 | 243.51M |
| September 30, 2017 | 261.39M |
| June 30, 2017 | 176.81M |
| March 31, 2017 | 166.21M |
| December 31, 2016 | 176.08M |
| September 30, 2016 | 86.07M |
| June 30, 2016 | 96.09M |
| March 31, 2016 | 87.27M |
| December 31, 2015 | 94.08M |
| September 30, 2015 | 42.09M |
| June 30, 2015 | 12.22M |
| December 31, 2014 | 17.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
70.78M
Minimum
Dec 2020
288.05M
Maximum
Jun 2021
193.29M
Average
218.35M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Aldeyra Therapeutics Inc | 141.30M |
| Akoya Biosciences Inc | 180.37M |
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 40.23M |
| Shareholders Equity (Quarterly) | 157.18M |
| Current Ratio | 4.163 |